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The bovine herpesvirus 1 (BHV-1) US ORF8 protein with homology to the Us9 protein of other alphaherpesviruses induces
apoptosis in rabbit kidney (RK13) cells without the presence of other BHV-1-encoded proteins. In this article, we have
characterized the cytotoxicity and growth behavior of a BHV-1 recombinant, BHV-1/D8, which fails to express the US ORF8
protein in infected cells. BHV-1/D8 exhibited a reduced cytotoxicity to RK13 cells when compared to the cytotoxicity of control
BHV-1 strains. In RK13 cells, the onset of apoptosis was not observed during the infection with BHV-1/D8, and the virus
multiplication of BHV-1/D8 was markedly greater than that of control viruses. However, virus release of progeny viruses from
the infected RK13 cells into culture supernatant was significantly decreased by the loss of the US ORF8 protein. These data
demonstrate that the US ORF8 protein activates the apoptotic process and facilitates virus release from the BHV-1-infectedINTRODUCTION
Bovine herpesvirus 1 (BHV-1), a member of the Alpha-
herpesvirinae subfamily (Roizman et al., 1992), causes in-
fectious bovine rhinotracheitis (IBR), a disease of major
economic concern with worldwide distribution (Yates,
1982). The nucleotide sequence analysis of the BHV-1 ge-
nome predicts that BHV-1 encodes at least 67 unique
genes and 2 genes that are both duplicated in the repeat
region (Schwyzer and Ackermann, 1996). The open reading
frame 8 (ORF8) within the unique short (US) segment of the
BHV-1 genome is known to be a homologue of the Us9
gene of herpes simplex virus type 1 (HSV-1) (McGeoch et
al., 1985; Leung-Tack et al., 1994). DNA sequences homol-
ogous to HSV-1 Us9 have been identified in the human
pathogens such as HSV-2 (Dolan et al., 1998) and varicella-
zoster virus (VZV) (Davison and Scott, 1986), as well as in
the animal pathogens such as pseudorabies virus (PrV)
(Petrovskis and Post, 1987; van Zijl et al., 1990), equine
herpes virus type 1 (Cullinane et al., 1988; Flowers and
O’Callaghan, 1992; Telford et al., 1992), feline herpesvirus 1
(Willemse et al., 1995), canine herpesvirus (Tyack et al.,
1997; Haanes and Tomlinson, 1998), and simian herpesvi-
rus B (Killeen et al., 1992). For HSV-1, it was shown that
HSV-1 Us9 is a virion structural protein localized in the
tegument (Frame et al., 1986). It was also suggested that
HSV-1 Us9 is ubiquitinated and interacts with the ubiquitin-
dependent pathway (Brandimarti and Roizman, 1997). For© 2002 Elsevier Science (USA)
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24PrV and VZV, Us9 homologous proteins are shown to be
phosphorylated proteins which are inserted into the viral
envelope as type II membrane proteins (Brideau et al., 1998;
Cohen et al., 2001).
For several alphaherpesviruses including BHV-1, Us9
homologous proteins are nonessential for viral growth
(Lomniczi et al., 1984; Mettenleiter et al., 1985; Long-
necker and Roizman, 1986; Petrovskis et al., 1986;
Umene, 1986; Brown and Harland, 1987; Rijsewijk et al.,
1999; Cohen et al., 2001). Although the HSV-1 Us9 is of no
importance for virulence in vivo (Nishiyama et al., 1993),
reduced virulence and restricted transneuronal spread of
Us9 null mutants are reported for PrV (Brideau et al.,
2000a,b).
Recently, we have identified a protein encoded by the
BHV-1 US ORF8 by using a polyclonal antiserum raised
against the US ORF8 protein expressed in Escherichia
coli and examined the effect of its expression in rabbit
kidney (RK13) cells (Nakamichi et al., 2002). Under high-
level expression of the US ORF8 protein, the apoptotic
process was activated in RK13 cells in the absence of
other BHV-1-encoded polypeptides. We have also dem-
onstrated that the apoptotic process was induced in
RK13 cells around 12–16 h after BHV-1 infection (Naka-
michi et al., 2001). However, it remains unknown whether
the apoptotic process in the BHV-1-infected RK13 cells is
activated by the expression of the US ORF8 protein. It is
also unclear whether the induction of apoptosis is ad-
vantageous to the BHV-1 replication in infected cells. Incells. © 2002 Elsevier Science (USA)
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this study, we have constructed a BHV-1 recombinant
which fails to express the US ORF8 protein. The goal ofhomol
this study is to elucidate whether the loss of the US ORF8
protein affects the apoptotic process in infected cells
and the growth characteristics of BHV-1.
RESULTS
Construction of BHV-1 recombinants
To examine the role of the US ORF8 protein in replica-
tive cycles of BHV-1, we constructed a BHV-1 mutant,
BHV-1/D8, which fails to express the US ORF8 protein.
BHV-1/D8 was generated by the insertion of the PrV
thymidine kinase (tk) gene into the coding region of US
ORF8 within the virus genome of IBRV(NG)dltk, which is
a tk-deletion mutant of wild-type BHV-1 (LA strain) (Kit et
al., 1992). To assess whether any unknown mutations
other than US ORF8 affect the characteristics of BHV-1/
D8, we also constructed a US ORF8-repaired revertant of
BHV-1/D8, designated as BHV-1/R8. A BHV-1 recombi-
nant, BHV-1/TF2-1, which carries the PrV tk gene at the
BHV-1 tk locus (Otsuka and Xuan, 1996), was used as a
control virus. To confirm the deletion and repair of the US
ORF8 protein in these recombinants, Western blot anal-
ysis was performed using antiserum specific for the
BHV-1 US ORF8 protein (Nakamichi et al., 2002). Madin–
Darby bovine kidney (MDBK) cells were mock-infected or
infected with BHV-1/TF2-1 (control strain), IBRV(NG)dltk
(parental strain of BHV-1/D8), BHV-1/D8, and BHV-1/R8 at
a multiplicity of infection (m.o.i.) of 10. After 24 h postin-
fection (p.i.), the infected cells were harvested, lysed, and
subjected to sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) and Western blotting as de-
scribed under Materials and Methods. As shown in Fig.
1, the US ORF8 protein with apparent molecular masses
of 27 and 32 kDa (Fig. 1, arrows) were detected in MDBK
cells infected with BHV-1/TF2-1 (Fig. 1, lane 2) and
IBRV(NG)dltk (Fig. 1, lane 3). When cells were infected
with BHV-1/D8, no specific protein was detected with
anti-US ORF8 protein antibodies (Fig. 1, lane 4). In con-
trast, the US ORF8-repaired revertant, BHV-1/R8, ex-
pressed the US ORF8 protein at similar levels that were
seen for the control strains (Fig. 1, lane 5).
Viability of cells infected with BHV-1
To compare the cytotoxicity of BHV-1/D8 with that of
the control strains, we next examined the viability of
MDBK and RK13 cells infected with BHV-1 recombinants
by using colorimetric 3-(4,5-dimethyl-2-thiazolyl)-2,5-di-
phenyl tetrazolium bromide (MTT), as described under
Materials and Methods. In viable cells, the mitochondrial
enzyme succinate dehydrogenase can catalyze MTT into
a formazan dye that absorbs light at 550 nm, and its
activity reflects the cell viability (Jordan et al., 1992). Cells
were infected with BHV-1 recombinants at an m.o.i. of 10,
and enzymatic activity was monitored during the course
of infection. The percentages of enzyme activity of the
BHV-1-infected cells were calculated with reference to
the values for mock-infected cells and are shown as
percentage of cell viability. As shown in Fig. 2A, when
MDBK cells were infected with the control BHV-1/TF2-1,
the enzyme activity decreased steeply and linearly be-
tween 0 and 48 h p.i., and the enzyme activity of MDBK
cells infected with BHV-1/TF2-1 or BHV-1/R8 was about
50% of that of the mock-infected control at 48 h p.i. At all
time points tested, the viability of MDBK cells infected
with BHV-1/D8 was similar to that infected with the con-
trol strains (Fig. 2A). These results indicate that the lack
of the US ORF8 protein did not affect the cytotoxicity of
BHV-1 in MDBK cells. When RK13 cells were infected
with BHV-1/TF2-1 or BHV-1/R8 (Fig. 2B), the enzyme ac-
tivity decreased steeply between 0 and 24 h and went on
decreasing gradually at later time points. At 48 h p.i., the
cell viability of RK13 cells infected with the control strains
was reduced to the similar levels that were seen for
MDBK cells. However, in RK13 cells infected with BHV-
1/D8, the enzyme activity dropped to about 80% of that of
the mock-infected control at 12 h p.i. and decreased
slightly between 12 to 48 h after infection (Fig. 2B). The
viability of RK13 cells infected with BHV-1/D8 was signif-
icantly higher (P  0.05) than that infected with BHV-1/
TF2-1 between 24 and 48 h after infection. These results
indicate that the BHV-1 mutant lacking the US ORF8
protein is less cytotoxic to RK13 cells than the control
BHV-1 viruses expressing the US ORF8 protein.
BHV-1 US ORF8 protein induces apoptosis in infected
RK13 cells
BHV-1 induces apoptotic cell death in different cell
types in different manners (Hanon et al., 1996, 1998;
FIG. 1. Western blot analysis of the BHV-1 US ORF8 protein. MDBK
cells were mock-infected (lane 1) or infected with BHV-1/TF2-1 (control
strain, lane 2), IBRV(NG)dltk (parental strain of BHV-1/D8, lane 3),
BHV-1/D8 (US ORF8-inactivated strain, lane 4), and BHV-1/R8 (US ORF8-
repaired strain, lane 5). At 24 h p.i., proteins in cell lysates were
separated by SDS–PAGE and subjected to Western blotting using
antiserum specific for BHV-1 US ORF8 protein. Arrows on the right
indicate the location of the US ORF8 proteins mentioned in the text, and
molecular mass standards (kDa) are shown on the left.
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Devireddy and Jones, 1999; Nakamichi et al., 2001). It has
been demonstrated that RK13 cells were highly suscep-
tible to induction of apoptosis by BHV-1 infection (Naka-
michi et al., 2001), while MDBK cells underwent apop-
totic cell death near the end of BHV-1 infection (De-
vireddy and Jones, 1999). It might be possible that the US
ORF8 protein is involved in apoptosis in RK13 cells in-
fected with BHV-1. The major characteristic features of
cells undergoing apoptosis are cleavage of genomic
DNA into oligonucleosomal DNA fragments (Wyllie, 1980;
Arends et al., 1990) and condensation of chromatin (Du-
vall and Wyllie, 1986; Martin et al., 1994). In the experi-
ments shown in Fig. 3, the fragmentation of genomic
DNA in cells infected with BHV-1/D8 was compared with
that infected with the control viruses. Cells were infected
with BHV-1 recombinants at an m.o.i. of 10, and at 10
(panel A), 20 (panel B), and 30 (panel C) h p.i., low
molecular weight DNAs were extracted, separated on a
1.5% agarose gel, and stained as described under Ma-
terials and Methods. For DNAs from MDBK cells mock-
infected or infected with BHV-1 recombinants, fragmen-
tation of DNAs was not seen at all time points tested (Fig.
3, lanes 1–4). In RK13 cells infected with the control
BHV-1/TF2-1, distinct DNA fragmentation patterns were
observed at 20 and 30 h p.i. (Figs. 3B and 3C, lanes 6).
However, DNAs from RK13 cells infected with BHV-1/D8
did not show any laddering patterns between 10 and 30 h
after infection (Figs. 3A–3C, lanes 7). The microscopic
observation of the nuclei of RK13 cells did not reveal any
nuclear condensation at 30 h after infection with BHV-
1/D8 (data not shown). The US ORF8-repaired mutant,
BHV-1/R8, induced apoptosis in RK13 cells similar to the
control BHV-1/TF2-1 (Figs. 3B and 3C, lanes 8). To con-
firm that the down-regulation of apoptosis in the BHV-1/
D8-infected RK13 cells is caused by the loss of the US
ORF8 protein, RK13 cells were transduced with recom-
binant baculovirus vectors and then infected with BHV-
1/D8. A recombinant baculovirus Ac/CA8, which carries
FIG. 3. DNA fragmentation in cells infected with BHV-1 recombi-
nants. MDBK cells (lanes 1–4) and RK13 cells (lanes 5–10) were mock-
infected (lanes 1 and 5) or infected with BHV-1/TF2-1 (lanes 2 and 6),
BHV-1/D8 (lanes 3 and 7), and BHV-1/R8 (lanes 4 and 8). Alternatively,
RK13 cells were transduced with recombinant baculoviruses Ac/PH8
(lane 9) or Ac/CA8 (lane 10 and 11) and then infected with BHV-1/D8
(lane 9 and 10) as described under Materials and Methods. At 10 h (A),
20 h (B), and 30 h (C) after infection, the low molecular weight DNAs
were extracted, electrophoresed, and stained.
FIG. 2. Viability of cells infected with BHV-1 recombinants. Semicon-
fluent monolayers of MDBK cells (A) and RK13 cells (B) were mock-
infected or infected with BHV-1/TF2-1 ({), BHV-1/D8 (F), and BHV-1/R8
(E) at an m.o.i. of 10. At time points indicated, the activity of mitochon-
drial succinate dehydrogenase in infected cells was determined by
using MTT assay as described under Materials and Methods. The
percentage of enzyme activity was calculated with reference to the
values for mock-infected cells and is shown as percentage of cell
viability. Mean values and standard deviations from the results of three
independent experiments are shown.
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the BHV-1 US ORF8 driven by the mammalian CAG pro-
moter, expresses the US ORF8 protein in mammalian
cells upon transduction (Nakamichi et al., 2002). A bac-
ulovirus Ac/PH8, which contains the BHV-1 US ORF8
downstream of the control of baculovirus polyhedrin pro-
moter, does not express the BHV-1 US ORF8 protein in
mammalian cells (Nakamichi et al., 2002) and is used as
a control baculovirus. When RK13 cells were transduced
with Ac/CA8 and infected with BHV-1/D8, DNA fragmen-
tation patterns were detected at 20 and 30 h after infec-
tion (Figs. 3B and 3C, lanes 10). The infection with BHV-
1/D8 did not appear to affect the occurrence of apoptotic
process in RK13 cells upon transduction with Ac/CA8
(data not shown). A similar experiment using Ac/PH8
instead of Ac/CA8 failed to demonstrate any patterns of
DNA fragmentation (Fig. 3, lane 9). Taken together, these
data suggest that the apoptotic process is activated in
infected RK13 cells by the expression of the US ORF8
protein.
Cell-to-cell spread of BHV-1/D8
To examine the effect of the knockout of the US ORF8
protein on the growth characteristics of BHV-1, the
plaque size of each BHV-1 recombinant on MDBK and
RK13 was measured at 48 h after infection. In MDBK
cells, plaque size of BHV-1/D8 was indistinguishable
from that of the control strains (Fig. 4A). However, in RK13
cells, BHV-1/D8 exhibited an increase in plaque size by
more than 20% when compared to that of BHV-1/TF2-1
(P  0.05) (Figs. 4B and 4C). To examine the virus
multiplication by cell-to-cell spread more quantitatively,
the multistep growth of BHV-1/D8 under semisolid me-
dium was compared to that of the control strains. MDBK
and RK13 cells were infected with BHV-1 recombinants
at a low m.o.i. and overlaid with semisolid medium con-
taining methylcellulose (MC, Sigma) to inhibit the ad-
sorption of mature virion released in the medium. At
different times after infection, the cell-associated prog-
eny viruses were titrated. As shown in Fig. 5A, all BHV-1
recombinants exhibited a linear increase in infectious
titers between 48 and 96 h p.i. in MDBK cells, suggesting
that the loss of the US ORF8 protein did not affect the
multistep growth of BHV-1 in MDBK cells. Figure 5B
shows the multistep growth of BHV-1 recombinants on
RK13 cell monolayers. The infectious titers of the control
strains, BHV-1/TF2-1 and BHV-1/R8, were increased
gradually between 24 and 72 h p.i., reaching a near-
plateau level at 72 h after infection. In contrast, BHV-1/D8
exhibited a steep increase in infectious titers between 48
and 96 h p.i., and at 72 and 96 h p.i., the virus titers of
BHV-1/D8 were significantly higher than those of the
control strains (P  0.01). These data suggest that
multistep replication of BHV-1 on RK13 cell monolayers
was increased by the lack of the US ORF8 protein.
One-step growth of BHV-1/D8
To further examine the effect of the US ORF8 protein on
the intracellular growth and egress from the infected
cells during BHV-1 replication, titers of cell-associated
and cell-free viruses were determined during the one-
step growth of the BHV-1 recombinants. MDBK (Fig. 6,
left) and RK13 (Fig. 6, right) cells were infected with
BHV-1 recombinants at an m.o.i. of 10, and the virus titers
of cell-associated viruses (Figs. 6A and 6B) and cell-free
viruses (Figs. 6C and 6D) were determined by plaque
titration. In MDBK cells, the growth curves of both cell-
associated and cell-free BHV-1/D8 were indistinguish-
able from those of control BHV-1/TF2-1 at all time points
(Figs. 6A and 6C), indicating that the US ORF8 protein
was of no importance for the one-step growth of BHV-1 in
MDBK cells. However, in RK13 cells, BHV-1/D8 showed a
steep increase in cell-associated viruses between 12
and 24 h p.i., and the virus titers of cell-associated
viruses of BHV-1/D8 were significantly higher than those
of the control strains (P  0.05) (Fig. 6B). Figure 6D
shows the infectious titers of cell-free viruses of BHV-1
progenies released from the infected RK13 cells. For the
control strains, BHV-1/TF2-1 and BHV-1/R8, the infec-
tious titers of cell-free viruses were increased steeply
and linearly between 12 and 36 h p.i., reaching a near
plateau level at 36 h p.i. (Fig. 6D). When compared to the
virus release of the control strains, BHV-1/D8 exhibited a
significant defect in virus release from the infected RK13
cells between 24 and 48 h p.i. (P  0.05) (Fig. 6D),
despite the fact that the infectious titers of cell-associ-
ated viruses were increased by the knockout of the US
ORF8 protein (Fig. 6B). The total virus yields of BHV-1/D8
in RK13 cells were significantly increased when com-
pared to those of the control strains (P  0.05) due to
the increase in cell-associated viruses (data not shown).
Taken together, these data indicate that the loss of the US
ORF8 protein increases the virus production in RK13
cells but causes defects in virus release from the in-
fected cells.
DISCUSSION
Infections with several alphaherpesviruses induce
apoptotic cell death in various cell types. PrV infection
induces apoptosis in infiltrating inflammatory cells (Ale-
man et al., 2001) and MDBK cells (Cheung et al., 2000).
Wild-type HSV-2 activates the apoptotic process in cul-
tured HEp-2 cells (Koyama et al., 1998). Although wild-
type HSV-1 does not induce apoptosis in cultured mam-
malian cells, it has been reported that the apoptotic
process is triggered during the infection with several
HSV-1 mutants lacking infected cell-specific protein 4
(ICP4), US3, or ICP27 (Leopardi et al., 1997; Galvan and
Roizman, 1998; Galvan et al., 1999; Aubert and Blaho,
1999; Galvan et al., 2000).
For BHV-1, it was reported that the attachment of
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BHV-1 virions to cells induces apoptotic cell death in
peripheral blood mononuclear cells and bovine B lym-
phoma (BL-3) cells (Hanon et al., 1996, 1998). Wild-type
BHV-1 also induces programmed cell death in nonlym-
phoid cell types such as MDBK cells (Devireddy and
Jones, 1999) and RK13 cells (Nakamichi et al., 2001).
However, alphaherpesvirus-encoded proteins that are
directly associated with the induction of apoptosis in
infected cells are not well understood.
In the recent study, we have demonstrated that the
transient expression of the BHV-1 US ORF8 protein acti-
vates the apoptotic process in RK13 cells without the
presence of other BHV-1-encoded proteins (Nakamichi
et al., 2002). In the present study, we have constructed a
BHV-1 recombinant, BHV-1/D8, which fails to express the
US ORF8 protein, and examined its cytotoxicity and
growth characteristics. In RK13 cells infected with BHV-
1/D8, the activation of apoptotic process was markedly
down-regulated. This observation clearly demonstrates
that the expression of the BHV-1 US ORF8 protein trig-
gers apoptotic process and exhibits cytotoxicity in in-
fected RK13 cells. In RK13 cells infected with BHV-1/D8,
the gradual decrease in cell viability during the course of
infection was seen, although no apoptotic process was
FIG. 4. Plaque size of BHV-1 recombinants on cell monolayers (A and B). Semiconfluent monolayers of MDBK cells (A) and RK13 cells (B) were
infected with BHV-1/TF2-1, BHV-1/D8, or BHV-1/R8. Cells were overlaid with semisolid medium and stained with crystal violet at 48 h after infection.
For each combination of virus and cell, the minimum diameters of 30 plaques were measured microscopically, and the percentages of plaque
diameter were calculated with reference to the values for plaque size of BHV-1/TF2-1. The vertical lines indicate standard errors. Morphologies of
plaques formed by BHV-1 recombinants on RK13 cell monolayers (C). RK13 cells were infected with BHV-1/TF2-1 or BHV-1/D8. After a 48-h incubation
at 37°C, cells were fixed, stained with crystal violet, and photographed. Representative plaques of each culture are shown. Original magnification,
200.
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observed (Fig. 2B). Previously, it was shown that the
expression of BHV-1-infected cell-specific protein 0
(BICP0) is toxic to mammalian cells (Steinmann et al.,
1998; Ciacci-Zanella et al., 1999), but BICP0 does not
appear to directly induce apoptosis (Inman et al., 2001).
The reduction in cell viability of the BHV-1/D8-infected
RK13 cells might be due to cytotoxic BHV-1-encoded
protein(s) such as BICP0.
In contrast to the susceptibility of RK13 cells to apop-
tosis (Nakamichi et al., 2001), MDBK cells are resistant to
the induction of apoptosis by BHV-1 infection and un-
dergo apoptosis near the end of BHV-1 infection (about
48 h p.i.) (Devireddy and Jones, 1999). From our previous
data, the production of the US ORF8 protein in infected
MDBK cells was at the similar level as seen in RK13 cells
(Nakamichi et al., 2002). It is unlikely that the low sus-
ceptibility of MDBK cells to apoptosis induced by BHV-1
is due to the low-level expression of the US ORF8 protein,
and it is not clear whether the activation of apoptotic
process in MDBK cells near the end of BHV-1 infection
(Devireddy and Jones, 1999) is associated with the ex-
pression of the US ORF8 protein. Taken together, it would
appear that the induction of apoptosis by the US ORF8
protein is cell-type specific, and the US ORF8 protein
does not activate the apoptotic process in MDBK cells.
Although BHV-1-induced apoptosis in lymphoid cells is
thought to be a mechanism to escape immune systems,
biological significance of apoptosis induced in nonlym-
phoid cells during BHV-1 infection is not well understood.
From the results of one-step growth analysis of BHV-1/
D8, it would appear that the knockout of the US ORF8
protein increases the production of progeny viruses in
RK13 cells (Fig. 6B). The increased multiplication of BHV-
1/D8 by cell-to-cell spread on RK13 cell monolayers (Fig.
5) can be explained by the enhanced intracellular pro-
duction of progeny viruses. The enhancement of virus
multiplication by the loss of the US ORF8 protein was
cell-type specific, because BHV-1/D8 exhibited one-step
multiplication similar to that of the control strains in
MDBK cells. It is likely that the down-regulation of apop-
tosis led to an increase in intracellular multiplication of
BHV-1/D8 in RK13 cells. It is also possible that the in-
creased viability of BHV-1/D8-infected RK13 cells re-
sulted in the enhanced production of BHV-1 gene prod-
ucts. The expression of the US ORF8 protein, which
directly induces apoptosis, seems to be disadvanta-
geous to BHV-1 replication in infected cells. However,
the lack of the US ORF8 protein caused a significant
defect in virus release of progeny BHV-1 from the in-
fected RK13 cells (Fig. 6D). In RK13 cells, the extracellular
viruses of BHV-1/D8 progeny were about 2% of the total
virus yields, despite the fact that more than 40% of
progeny viruses of BHV-1/D8 were released from the
FIG. 6. One-step growth kinetics of BHV-1 recombinants. MDBK cells
(left) and RK13 cells (right) were infected with BHV-1/TF2-1 ({), BHV-
1/D8 (F), and BHV-1/R8 (E) at an m.o.i. of 10 and overlaid with culture
medium. At time points indicated, the titers of cell-associated viruses (A
and B) and cell-free viruses (C and D) were determined as described
under Materials and Methods. Mean values and standard deviation
from the results of three independent experiments are shown.
FIG. 5. Multistep growth of BHV-1 recombinants by cell-to-cell
spread. Semiconfluent monolayers of MDBK cells (A) and RK13 cells (B)
were infected with BHV-1/TF2-1 ({), BHV-1/D8 (F), and BHV-1/R8 (E) at
an m.o.i. of 0.001 and overlaid with semisolid medium. At time points
indicated, the infected cells were harvested, and the titers of cell-
associated viruses were titrated as described under Materials and
Methods. Mean values and standard deviation from the results of three
independent experiments are shown.
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infected MDBK cells. These results indicate that the virus
release of BHV-1 is strictly impaired in RK13 cells and
that the US ORF8 protein is required for efficient virus
release from the BHV-1-infected cells. Previously, it has
been reported that the apoptotic process is necessary
for the efficient virus release of BHV-1 virions from in-
fected cells (Devireddy and Jones, 1999). It likely that the
US ORF8 protein induces apoptosis in a cell-type-depen-
dent manner to facilitate BHV-1 release from infected
cells.
MATERIALS AND METHODS
Cells and viruses
MDBK and RK13 cells were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM, Nissui, Japan) con-
taining 10% FCS and 100 g/ml of kanamycin. IBRV(NG-
)dltk, which is a tk-deletion mutant of wild-type BHV-1 (LA
strain), has been described earlier (Kit et al., 1992). A
BHV-1 recombinant, BHV-1/TF2-1, which carries PrV tk
gene at the BHV-1 tk locus, has been described in our
previous article (Otsuka and Xuan, 1996). Two baculovi-
rus recombinants, designated as Ac/CA8 and Ac/PH8,
have been described in our previous article (Nakamichi
et al., 2002). In Ac/CA8, the BHV-1 US ORF8 driven by the
mammalian CAG promoter (Niwa et al., 1991) was inte-
grated into the baculovirus genome, and thus it ex-
presses the BHV-1 US ORF8 protein in mammalian cells.
Ac/PH8 is a baculovirus recombinant, which carries the
BHV-1 US ORF8 under the control of baculovirus poly-
hedrin promoter, and is used as a control virus.
Construction of BHV-1 recombinants
The 2817-bp DNA sequence, which encompasses the
BHV-1 US ORF8, was amplified by polymerase chain
reaction (PCR) using a set of primers termed BUS8NRF
(5 CGT-GTA-CTT-CCT-GTA-CGA-CC 3) and BUS8NRR
(5 GAC-TCC-AGC-AGC-GAA-GAC-TA 3) and a DNA tem-
plate obtained from MDBK cells infected with wild-type
BHV-1 (LA strain). The PCR reaction was carried out by
using TaKaRa LA Taq polymerase and GC buffer II
(TaKaRa) according to the manufacturer’s recommenda-
tion. The amplified product was cloned into TA cloning
vector pCR2.1 (Invitrogen) according to the manufactur-
er’s protocol, and the resulting plasmid was designated
as pCR-BUS8NR. The PrV tk region was inserted at the
HincII site within US ORF8 of pCR-BUS8NR, and the
resulting plasmid was designated as pCR-BUS8TK.
A BHV-1 mutant, BHV-1/D8, in which the coding se-
quence of US ORF8 was interrupted by the PrV tk gene,
was generated by homologous recombination method
(Otsuka and Xuan, 1996) using transfer vector pCR-
BUS8TK and IBRV(NG)dltk as a parental virus strain. The
US ORF8-revertant, designated here as BHV-1/R8, was
generated by homologous recombination method
(Otsuka and Xuan, 1996) using transfer vector plasmid
pCR-BUS8NR and BHV-1/D8 as a parental virus.
Antiserum
A polyclonal antiserum raised against the US ORF8
protein expressed in E. coli (Nakamichi et al., 2002) was
used at a dilution of 1:100 for Western blotting.
Western blotting
Western blot analysis was performed according to the
procedure described earlier (Nakamichi et al., 2001,
2002). Briefly, MDBK cells in six-well culture plates were
mock-infected or infected with BHV-1 strains at an m.o.i.
of 10 and lysed at 24 h after infection. Proteins were
separated under reducing conditions in 0.4% SDS–12%
polyacrylamide gels and were transferred to polyvinyli-
dene difluoride membranes (Millipore). Proteins were
reacted with antiserum against the US ORF8 protein and
stained with a horseradish peroxidase (HRP)-linked sec-
ondary antibody.
Measurement of cell viability
Cytotoxicity assay using MTT was carried out accord-
ing to the procedure described previously (Kurita-Ochiai
et al., 1997, 1998). Semiconfluent monolayers of MDBK
and RK13 cells in 48-well culture plates were mock-
infected or infected with BHV-1 recombinant at an m.o.i.
of 10 for 1 h at 37°C. The cells were washed with
phosphate-buffered saline (PBS) and overlaid with 200 l
of culture medium. At different times p.i., 20 l of MTT
solution (5 mg/ml in PBS) was added to the culture
medium, and the cells were incubated at 37°C. After 2-h
incubation period, cells and supernatants were har-
vested and centrifuged at 10,000 g for 1 min. The precip-
itates were solubilized in 1 ml each of dimethylsulfoxide,
and absorbance at 550 nm was determined on a spec-
trophotometer.
DNA fragmentation assay
DNA fragmentation analysis for detection of apoptosis
was performed as described previously (Takashima et
al., 1999). Briefly, semiconfluent monolayers of MDBK
and RK13 cells in six-well culture dishes were mock-
infected or infected with BHV-1 recombinants at an m.o.i.
of 10 for 1 h at 37°C. Alternatively, cells were incubated
with 100 plaque forming units (PFU)/cell of recombinant
baculoviruses for 1 h at 37°C, washed, and then infected
with BHV-1/D8 as described above. The cells were over-
laid with culture medium and harvested at different time
points. DNA from each sample was extracted, dissolved
in 20 l of TE buffer (10 mM Tris–HCl, 1 mM EDTA, pH
8.0), and subjected to electrophoresis on a 1.5% agarose
gel. The DNA was visualized by ethidium bromide stain-
ing and photographed under UV light.
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Measurement of plaque size
The plaque size of BHV-1 recombinants was mea-
sured after plaque titration on MDBK and RK13 cells. For
each combination of virus and cell, the minimum diam-
eter of 30 plaques was measured microscopically at 48 h
p.i., and the percentages of plaque diameter were cal-
culated with reference to the values for size of plaques
formed by BHV-1/TF2-1.
Multistep growth kinetics of BHV-1 recombinants
Semiconfluent monolayers of MDBK and RK13 cells
grown in six-well culture dishes were infected with
BHV-1 recombinants at an m.o.i. of 0.001 for 1 h. The cells
were overlaid with culture medium containing 0.5% (w/v)
MC (MC medium) and then incubated at 37°C. At differ-
ent times postinfection, cells and supernatants were
harvested and centrifuged at 10,000 g for 1 min. The cells
were resuspended in 400 l of culture medium and
subjected to freeze-thaw (80 to 37°C) cycles and
plaque titration on MDBK cell monolayer.
One-step growth kinetics of BHV-1 recombinants
One-step multiplication of BHV-1 recombinants was
examined essentially as described previously (Nakami-
chi and Otsuka, 2000). Cells in 12-well culture dishes
were infected with BHV-1 recombinants at an m.o.i. of 10
for 1 h. The cells were washed with PBS, treated with
low-pH solution (40 mM citric acid, 10 mM KCl, 135 mM
NaCl) to inactivate extracellular virus (van Drunen Littel-
van den Hurk et al., 1996), and overlaid with 1 ml of
culture medium. At different times p.i., cells and super-
natants were separated by centrifugation at 5000 g for 3
min. The supernatants or the cells resuspended in 1 ml
of culture medium were subjected to freeze-thaw cycles.
Virus titer was determined on MDBK cells monolayers.
Plaque titration
For titration of progeny viruses, MDBK cell monolayers
in 96-well culture plates were infected with BHV-1 inoc-
ulum at a three-fold dilution series for 1 h and overlaid
with MC medium. After 2 days of incubation at 37°C,
cells were fixed with ethanol and stained with 0.15% (w/v)
crystal violet, and plaques were counted.
Statistics
The significance of differences between groups was
determined by Student’s t test.
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